nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—fourth ventricle—malignant glioma	0.091	0.381	CbGeAlD
Tapentadol—OPRM1—telencephalic ventricle—malignant glioma	0.0242	0.101	CbGeAlD
Tapentadol—Altered state of consciousness—Temozolomide—malignant glioma	0.0141	0.0373	CcSEcCtD
Tapentadol—Edrophonium—BCHE—malignant glioma	0.0119	0.518	CrCbGaD
Tapentadol—Rivastigmine—BCHE—malignant glioma	0.0111	0.482	CrCbGaD
Tapentadol—Lung disorder—Temozolomide—malignant glioma	0.00922	0.0244	CcSEcCtD
Tapentadol—OPRD1—telencephalon—malignant glioma	0.00851	0.0356	CbGeAlD
Tapentadol—Memory impairment—Temozolomide—malignant glioma	0.00831	0.022	CcSEcCtD
Tapentadol—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00793	0.021	CcSEcCtD
Tapentadol—Disturbance in attention—Temozolomide—malignant glioma	0.00753	0.0199	CcSEcCtD
Tapentadol—Thinking abnormal—Carmustine—malignant glioma	0.00737	0.0195	CcSEcCtD
Tapentadol—Drug interaction—Carmustine—malignant glioma	0.00728	0.0192	CcSEcCtD
Tapentadol—HTR3A—brainstem—malignant glioma	0.00713	0.0298	CbGeAlD
Tapentadol—Coordination abnormal—Carmustine—malignant glioma	0.00687	0.0182	CcSEcCtD
Tapentadol—Coordination abnormal—Temozolomide—malignant glioma	0.00664	0.0176	CcSEcCtD
Tapentadol—OPRM1—brainstem—malignant glioma	0.00654	0.0274	CbGeAlD
Tapentadol—Depressed level of consciousness—Carmustine—malignant glioma	0.00652	0.0172	CcSEcCtD
Tapentadol—HTR3A—telencephalon—malignant glioma	0.00633	0.0265	CbGeAlD
Tapentadol—Depressed level of consciousness—Temozolomide—malignant glioma	0.0063	0.0166	CcSEcCtD
Tapentadol—Mental disability—Carmustine—malignant glioma	0.00586	0.0155	CcSEcCtD
Tapentadol—OPRM1—telencephalon—malignant glioma	0.0058	0.0243	CbGeAlD
Tapentadol—Mental disability—Temozolomide—malignant glioma	0.00566	0.015	CcSEcCtD
Tapentadol—SLC6A4—brainstem—malignant glioma	0.00544	0.0228	CbGeAlD
Tapentadol—Hot flush—Temozolomide—malignant glioma	0.00506	0.0134	CcSEcCtD
Tapentadol—Menopausal symptoms—Temozolomide—malignant glioma	0.00502	0.0133	CcSEcCtD
Tapentadol—OPRD1—central nervous system—malignant glioma	0.00483	0.0202	CbGeAlD
Tapentadol—SLC6A4—telencephalon—malignant glioma	0.00482	0.0202	CbGeAlD
Tapentadol—SLC6A2—brainstem—malignant glioma	0.00479	0.02	CbGeAlD
Tapentadol—OPRK1—central nervous system—malignant glioma	0.00463	0.0194	CbGeAlD
Tapentadol—Ataxia—Carmustine—malignant glioma	0.00461	0.0122	CcSEcCtD
Tapentadol—OPRK1—cerebellum—malignant glioma	0.00453	0.019	CbGeAlD
Tapentadol—Ataxia—Temozolomide—malignant glioma	0.00445	0.0118	CcSEcCtD
Tapentadol—Breast disorder—Temozolomide—malignant glioma	0.00428	0.0113	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00426	0.0113	CcSEcCtD
Tapentadol—SLC6A2—telencephalon—malignant glioma	0.00425	0.0178	CbGeAlD
Tapentadol—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00418	0.011	CcSEcCtD
Tapentadol—OPRM1—midbrain—malignant glioma	0.00417	0.0174	CbGeAlD
Tapentadol—OPRM1—spinal cord—malignant glioma	0.00406	0.017	CbGeAlD
Tapentadol—OPRD1—brain—malignant glioma	0.00384	0.0161	CbGeAlD
Tapentadol—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0038	0.0101	CcSEcCtD
Tapentadol—Pollakiuria—Temozolomide—malignant glioma	0.00378	0.00999	CcSEcCtD
Tapentadol—Erectile dysfunction—Temozolomide—malignant glioma	0.00377	0.00996	CcSEcCtD
Tapentadol—Depression—Carmustine—malignant glioma	0.00377	0.00995	CcSEcCtD
Tapentadol—Weight decreased—Temozolomide—malignant glioma	0.0037	0.00979	CcSEcCtD
Tapentadol—OPRK1—brain—malignant glioma	0.00368	0.0154	CbGeAlD
Tapentadol—Urinary tract infection—Carmustine—malignant glioma	0.00367	0.0097	CcSEcCtD
Tapentadol—Infestation—Temozolomide—malignant glioma	0.00365	0.00964	CcSEcCtD
Tapentadol—Infestation NOS—Temozolomide—malignant glioma	0.00365	0.00964	CcSEcCtD
Tapentadol—Depression—Temozolomide—malignant glioma	0.00364	0.00962	CcSEcCtD
Tapentadol—HTR3A—central nervous system—malignant glioma	0.0036	0.0151	CbGeAlD
Tapentadol—Urinary tract infection—Temozolomide—malignant glioma	0.00355	0.00937	CcSEcCtD
Tapentadol—SLC6A4—midbrain—malignant glioma	0.00346	0.0145	CbGeAlD
Tapentadol—SLC6A4—spinal cord—malignant glioma	0.00338	0.0142	CbGeAlD
Tapentadol—Hypoaesthesia—Carmustine—malignant glioma	0.00337	0.00891	CcSEcCtD
Tapentadol—Hallucination—Carmustine—malignant glioma	0.00337	0.00891	CcSEcCtD
Tapentadol—SLC6A2—medulla oblongata—malignant glioma	0.00334	0.014	CbGeAlD
Tapentadol—Connective tissue disorder—Carmustine—malignant glioma	0.00333	0.0088	CcSEcCtD
Tapentadol—OPRM1—central nervous system—malignant glioma	0.0033	0.0138	CbGeAlD
Tapentadol—Visual impairment—Carmustine—malignant glioma	0.00327	0.00863	CcSEcCtD
Tapentadol—Hypoaesthesia—Temozolomide—malignant glioma	0.00326	0.00861	CcSEcCtD
Tapentadol—Hallucination—Temozolomide—malignant glioma	0.00326	0.00861	CcSEcCtD
Tapentadol—Urinary tract disorder—Temozolomide—malignant glioma	0.00324	0.00855	CcSEcCtD
Tapentadol—Connective tissue disorder—Temozolomide—malignant glioma	0.00322	0.00851	CcSEcCtD
Tapentadol—Urethral disorder—Temozolomide—malignant glioma	0.00321	0.00849	CcSEcCtD
Tapentadol—Eye disorder—Carmustine—malignant glioma	0.00317	0.00837	CcSEcCtD
Tapentadol—Visual impairment—Temozolomide—malignant glioma	0.00316	0.00834	CcSEcCtD
Tapentadol—Eye disorder—Temozolomide—malignant glioma	0.00306	0.00809	CcSEcCtD
Tapentadol—Cardiac disorder—Temozolomide—malignant glioma	0.00304	0.00803	CcSEcCtD
Tapentadol—Angiopathy—Temozolomide—malignant glioma	0.00297	0.00785	CcSEcCtD
Tapentadol—Mental disorder—Carmustine—malignant glioma	0.00297	0.00785	CcSEcCtD
Tapentadol—Immune system disorder—Temozolomide—malignant glioma	0.00296	0.00782	CcSEcCtD
Tapentadol—Mediastinal disorder—Temozolomide—malignant glioma	0.00295	0.0078	CcSEcCtD
Tapentadol—Malnutrition—Carmustine—malignant glioma	0.00295	0.0078	CcSEcCtD
Tapentadol—Chills—Temozolomide—malignant glioma	0.00294	0.00777	CcSEcCtD
Tapentadol—Mental disorder—Temozolomide—malignant glioma	0.00287	0.00758	CcSEcCtD
Tapentadol—HTR3A—brain—malignant glioma	0.00286	0.012	CbGeAlD
Tapentadol—Malnutrition—Temozolomide—malignant glioma	0.00285	0.00754	CcSEcCtD
Tapentadol—Vision blurred—Carmustine—malignant glioma	0.00278	0.00735	CcSEcCtD
Tapentadol—Tremor—Carmustine—malignant glioma	0.00276	0.00731	CcSEcCtD
Tapentadol—SLC6A4—central nervous system—malignant glioma	0.00274	0.0115	CbGeAlD
Tapentadol—Agitation—Carmustine—malignant glioma	0.00271	0.00717	CcSEcCtD
Tapentadol—Vision blurred—Temozolomide—malignant glioma	0.00269	0.0071	CcSEcCtD
Tapentadol—Tremor—Temozolomide—malignant glioma	0.00267	0.00706	CcSEcCtD
Tapentadol—Agitation—Temozolomide—malignant glioma	0.00262	0.00693	CcSEcCtD
Tapentadol—CYP2D6—brainstem—malignant glioma	0.00262	0.011	CbGeAlD
Tapentadol—OPRM1—brain—malignant glioma	0.00262	0.011	CbGeAlD
Tapentadol—Angioedema—Temozolomide—malignant glioma	0.00261	0.00689	CcSEcCtD
Tapentadol—Vertigo—Temozolomide—malignant glioma	0.00256	0.00677	CcSEcCtD
Tapentadol—Convulsion—Carmustine—malignant glioma	0.00256	0.00676	CcSEcCtD
Tapentadol—Palpitations—Temozolomide—malignant glioma	0.00252	0.00666	CcSEcCtD
Tapentadol—Anxiety—Carmustine—malignant glioma	0.0025	0.00662	CcSEcCtD
Tapentadol—Cough—Temozolomide—malignant glioma	0.00249	0.00658	CcSEcCtD
Tapentadol—Convulsion—Temozolomide—malignant glioma	0.00247	0.00653	CcSEcCtD
Tapentadol—Confusional state—Carmustine—malignant glioma	0.00243	0.00642	CcSEcCtD
Tapentadol—Arthralgia—Temozolomide—malignant glioma	0.00243	0.00642	CcSEcCtD
Tapentadol—Anxiety—Temozolomide—malignant glioma	0.00242	0.00639	CcSEcCtD
Tapentadol—SLC6A2—central nervous system—malignant glioma	0.00241	0.0101	CbGeAlD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00241	0.00637	CcSEcCtD
Tapentadol—Oedema—Carmustine—malignant glioma	0.00241	0.00636	CcSEcCtD
Tapentadol—Infection—Carmustine—malignant glioma	0.00239	0.00632	CcSEcCtD
Tapentadol—Dry mouth—Temozolomide—malignant glioma	0.00237	0.00627	CcSEcCtD
Tapentadol—Tachycardia—Carmustine—malignant glioma	0.00235	0.00621	CcSEcCtD
Tapentadol—Confusional state—Temozolomide—malignant glioma	0.00235	0.0062	CcSEcCtD
Tapentadol—Anaphylactic shock—Temozolomide—malignant glioma	0.00233	0.00615	CcSEcCtD
Tapentadol—Oedema—Temozolomide—malignant glioma	0.00233	0.00615	CcSEcCtD
Tapentadol—CYP2D6—telencephalon—malignant glioma	0.00233	0.00974	CbGeAlD
Tapentadol—Infection—Temozolomide—malignant glioma	0.00231	0.00611	CcSEcCtD
Tapentadol—Nervous system disorder—Temozolomide—malignant glioma	0.00228	0.00603	CcSEcCtD
Tapentadol—Skin disorder—Temozolomide—malignant glioma	0.00226	0.00597	CcSEcCtD
Tapentadol—Hypotension—Carmustine—malignant glioma	0.00225	0.00595	CcSEcCtD
Tapentadol—Hyperhidrosis—Temozolomide—malignant glioma	0.00225	0.00595	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00219	0.0058	CcSEcCtD
Tapentadol—Insomnia—Carmustine—malignant glioma	0.00218	0.00576	CcSEcCtD
Tapentadol—SLC6A4—brain—malignant glioma	0.00218	0.00911	CbGeAlD
Tapentadol—Paraesthesia—Carmustine—malignant glioma	0.00216	0.00572	CcSEcCtD
Tapentadol—Dyspnoea—Carmustine—malignant glioma	0.00215	0.00567	CcSEcCtD
Tapentadol—Somnolence—Carmustine—malignant glioma	0.00214	0.00566	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00212	0.0056	CcSEcCtD
Tapentadol—Insomnia—Temozolomide—malignant glioma	0.0021	0.00556	CcSEcCtD
Tapentadol—Decreased appetite—Carmustine—malignant glioma	0.00209	0.00553	CcSEcCtD
Tapentadol—Paraesthesia—Temozolomide—malignant glioma	0.00209	0.00552	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00208	0.00549	CcSEcCtD
Tapentadol—Dyspnoea—Temozolomide—malignant glioma	0.00207	0.00548	CcSEcCtD
Tapentadol—Somnolence—Temozolomide—malignant glioma	0.00207	0.00547	CcSEcCtD
Tapentadol—Constipation—Carmustine—malignant glioma	0.00206	0.00544	CcSEcCtD
Tapentadol—Dyspepsia—Temozolomide—malignant glioma	0.00205	0.00541	CcSEcCtD
Tapentadol—Decreased appetite—Temozolomide—malignant glioma	0.00202	0.00535	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00201	0.00531	CcSEcCtD
Tapentadol—Fatigue—Temozolomide—malignant glioma	0.00201	0.0053	CcSEcCtD
Tapentadol—Constipation—Temozolomide—malignant glioma	0.00199	0.00526	CcSEcCtD
Tapentadol—Feeling abnormal—Carmustine—malignant glioma	0.00198	0.00524	CcSEcCtD
Tapentadol—Feeling abnormal—Temozolomide—malignant glioma	0.00192	0.00507	CcSEcCtD
Tapentadol—SLC6A2—brain—malignant glioma	0.00192	0.00802	CbGeAlD
Tapentadol—Urticaria—Temozolomide—malignant glioma	0.00185	0.00489	CcSEcCtD
Tapentadol—Hypersensitivity—Carmustine—malignant glioma	0.00177	0.00469	CcSEcCtD
Tapentadol—Asthenia—Carmustine—malignant glioma	0.00173	0.00457	CcSEcCtD
Tapentadol—Hypersensitivity—Temozolomide—malignant glioma	0.00171	0.00453	CcSEcCtD
Tapentadol—Asthenia—Temozolomide—malignant glioma	0.00167	0.00441	CcSEcCtD
Tapentadol—Diarrhoea—Carmustine—malignant glioma	0.00165	0.00435	CcSEcCtD
Tapentadol—Pruritus—Temozolomide—malignant glioma	0.00165	0.00435	CcSEcCtD
Tapentadol—Dizziness—Carmustine—malignant glioma	0.00159	0.00421	CcSEcCtD
Tapentadol—Diarrhoea—Temozolomide—malignant glioma	0.00159	0.00421	CcSEcCtD
Tapentadol—Dizziness—Temozolomide—malignant glioma	0.00154	0.00407	CcSEcCtD
Tapentadol—Vomiting—Carmustine—malignant glioma	0.00153	0.00405	CcSEcCtD
Tapentadol—Rash—Carmustine—malignant glioma	0.00152	0.00401	CcSEcCtD
Tapentadol—Dermatitis—Carmustine—malignant glioma	0.00152	0.00401	CcSEcCtD
Tapentadol—Headache—Carmustine—malignant glioma	0.00151	0.00399	CcSEcCtD
Tapentadol—Vomiting—Temozolomide—malignant glioma	0.00148	0.00391	CcSEcCtD
Tapentadol—Rash—Temozolomide—malignant glioma	0.00147	0.00388	CcSEcCtD
Tapentadol—Dermatitis—Temozolomide—malignant glioma	0.00147	0.00387	CcSEcCtD
Tapentadol—Headache—Temozolomide—malignant glioma	0.00146	0.00385	CcSEcCtD
Tapentadol—Nausea—Carmustine—malignant glioma	0.00143	0.00378	CcSEcCtD
Tapentadol—Nausea—Temozolomide—malignant glioma	0.00138	0.00365	CcSEcCtD
Tapentadol—CYP2D6—central nervous system—malignant glioma	0.00132	0.00553	CbGeAlD
Tapentadol—CYP2D6—cerebellum—malignant glioma	0.00129	0.00541	CbGeAlD
Tapentadol—CYP2D6—brain—malignant glioma	0.00105	0.00439	CbGeAlD
Tapentadol—OPRK1—Signaling Pathways—PTK2—malignant glioma	7.92e-05	0.00022	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL8—malignant glioma	7.88e-05	0.000219	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KNG1—malignant glioma	7.85e-05	0.000218	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—malignant glioma	7.8e-05	0.000217	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HES1—malignant glioma	7.78e-05	0.000216	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TERT—malignant glioma	7.77e-05	0.000216	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2B6—malignant glioma	7.74e-05	0.000215	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NCOR1—malignant glioma	7.73e-05	0.000215	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—IDH1—malignant glioma	7.69e-05	0.000214	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.69e-05	0.000214	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2B6—malignant glioma	7.67e-05	0.000213	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—RAF1—malignant glioma	7.63e-05	0.000212	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PDGFB—malignant glioma	7.59e-05	0.000211	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FGFR1—malignant glioma	7.55e-05	0.00021	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—malignant glioma	7.53e-05	0.000209	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT2—malignant glioma	7.52e-05	0.000209	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK1—malignant glioma	7.48e-05	0.000208	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CB—malignant glioma	7.45e-05	0.000207	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SPHK1—malignant glioma	7.45e-05	0.000207	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HIF1A—malignant glioma	7.43e-05	0.000207	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PDGFRA—malignant glioma	7.41e-05	0.000206	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CG—malignant glioma	7.31e-05	0.000203	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2C18—malignant glioma	7.29e-05	0.000203	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CD—malignant glioma	7.22e-05	0.000201	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SPP1—malignant glioma	7.19e-05	0.0002	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CAV1—malignant glioma	7.19e-05	0.0002	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL8—malignant glioma	7.16e-05	0.000199	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—KDR—malignant glioma	7.11e-05	0.000198	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—IDH1—malignant glioma	7.08e-05	0.000197	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARG—malignant glioma	7.05e-05	0.000196	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—IDH1—malignant glioma	7.02e-05	0.000195	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP3—malignant glioma	6.95e-05	0.000193	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CB—malignant glioma	6.93e-05	0.000193	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN2B—malignant glioma	6.89e-05	0.000192	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.88e-05	0.000191	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SPHK1—malignant glioma	6.85e-05	0.00019	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FN1—malignant glioma	6.84e-05	0.00019	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—F2—malignant glioma	6.84e-05	0.00019	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—malignant glioma	6.84e-05	0.00019	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TERT—malignant glioma	6.82e-05	0.000189	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SPHK1—malignant glioma	6.79e-05	0.000189	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—BAD—malignant glioma	6.76e-05	0.000188	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2C18—malignant glioma	6.71e-05	0.000186	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOTCH1—malignant glioma	6.7e-05	0.000186	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTK2—malignant glioma	6.69e-05	0.000186	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	6.66e-05	0.000185	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PDGFB—malignant glioma	6.65e-05	0.000185	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2C18—malignant glioma	6.65e-05	0.000185	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FGFR1—malignant glioma	6.62e-05	0.000184	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HES1—malignant glioma	6.57e-05	0.000183	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CD80—malignant glioma	6.56e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CG—malignant glioma	6.55e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APC—malignant glioma	6.55e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NCOR1—malignant glioma	6.54e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HIF1A—malignant glioma	6.52e-05	0.000181	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CAV1—malignant glioma	6.52e-05	0.000181	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGF—malignant glioma	6.47e-05	0.00018	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—RAF1—malignant glioma	6.45e-05	0.000179	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTPN11—malignant glioma	6.43e-05	0.000179	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CD—malignant glioma	6.42e-05	0.000178	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—malignant glioma	6.37e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CAV1—malignant glioma	6.31e-05	0.000175	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.3e-05	0.000175	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.27e-05	0.000174	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.26e-05	0.000174	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	6.26e-05	0.000174	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KDR—malignant glioma	6.23e-05	0.000173	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.23e-05	0.000173	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—BRAF—malignant glioma	6.16e-05	0.000171	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SPP1—malignant glioma	6.08e-05	0.000169	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	6.05e-05	0.000168	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.05e-05	0.000168	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—F2—malignant glioma	6e-05	0.000167	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FN1—malignant glioma	6e-05	0.000167	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT2—malignant glioma	5.99e-05	0.000167	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—EGFR—malignant glioma	5.97e-05	0.000166	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CG—malignant glioma	5.94e-05	0.000165	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—BAD—malignant glioma	5.93e-05	0.000165	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTT1—malignant glioma	5.9e-05	0.000164	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOTCH1—malignant glioma	5.87e-05	0.000163	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—malignant glioma	5.78e-05	0.000161	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TERT—malignant glioma	5.76e-05	0.00016	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CD—malignant glioma	5.76e-05	0.00016	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CD80—malignant glioma	5.75e-05	0.00016	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CG—malignant glioma	5.74e-05	0.00016	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APC—malignant glioma	5.74e-05	0.00016	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARG—malignant glioma	5.73e-05	0.000159	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.71e-05	0.000159	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PIK3CA—malignant glioma	5.7e-05	0.000158	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGF—malignant glioma	5.68e-05	0.000158	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTPN11—malignant glioma	5.64e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—KRAS—malignant glioma	5.64e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PDGFB—malignant glioma	5.62e-05	0.000156	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CB—malignant glioma	5.6e-05	0.000156	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FGFR1—malignant glioma	5.59e-05	0.000155	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—malignant glioma	5.55e-05	0.000154	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS1—malignant glioma	5.53e-05	0.000154	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.51e-05	0.000153	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FGF2—malignant glioma	5.51e-05	0.000153	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HIF1A—malignant glioma	5.51e-05	0.000153	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.51e-05	0.000153	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTT1—malignant glioma	5.43e-05	0.000151	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—BRAF—malignant glioma	5.4e-05	0.00015	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTT1—malignant glioma	5.38e-05	0.000149	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CAV1—malignant glioma	5.33e-05	0.000148	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KDR—malignant glioma	5.27e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT2—malignant glioma	5.25e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—EGFR—malignant glioma	5.23e-05	0.000145	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CD—malignant glioma	5.22e-05	0.000145	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	5.18e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MDM2—malignant glioma	5.16e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RAF1—malignant glioma	5.14e-05	0.000143	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—BCHE—malignant glioma	5.14e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ERBB2—malignant glioma	5.09e-05	0.000141	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS1—malignant glioma	5.08e-05	0.000141	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC5A5—malignant glioma	5.08e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FN1—malignant glioma	5.07e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—F2—malignant glioma	5.07e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	5.05e-05	0.00014	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS1—malignant glioma	5.04e-05	0.00014	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.02e-05	0.00014	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	5.02e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—BAD—malignant glioma	5.01e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	5e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	4.96e-05	0.000138	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—KRAS—malignant glioma	4.94e-05	0.000137	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CD80—malignant glioma	4.86e-05	0.000135	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APC—malignant glioma	4.85e-05	0.000135	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	4.85e-05	0.000135	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTEN—malignant glioma	4.84e-05	0.000134	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FGF2—malignant glioma	4.83e-05	0.000134	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL8—malignant glioma	4.82e-05	0.000134	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.8e-05	0.000133	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGF—malignant glioma	4.8e-05	0.000133	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTPN11—malignant glioma	4.77e-05	0.000133	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.76e-05	0.000132	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—BCHE—malignant glioma	4.73e-05	0.000131	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—BCHE—malignant glioma	4.69e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC5A5—malignant glioma	4.67e-05	0.00013	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	4.66e-05	0.000129	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC5A5—malignant glioma	4.63e-05	0.000129	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CASP3—malignant glioma	4.62e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—malignant glioma	4.61e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—BRAF—malignant glioma	4.56e-05	0.000127	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CB—malignant glioma	4.55e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	4.54e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MDM2—malignant glioma	4.52e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RAF1—malignant glioma	4.51e-05	0.000125	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—malignant glioma	4.51e-05	0.000125	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ERBB2—malignant glioma	4.46e-05	0.000124	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT2—malignant glioma	4.44e-05	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EGFR—malignant glioma	4.42e-05	0.000123	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	4.4e-05	0.000122	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.38e-05	0.000122	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—malignant glioma	4.36e-05	0.000121	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.34e-05	0.000121	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTEN—malignant glioma	4.34e-05	0.000121	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	4.27e-05	0.000119	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AKT1—malignant glioma	4.23e-05	0.000118	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL8—malignant glioma	4.23e-05	0.000118	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.23e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—KRAS—malignant glioma	4.18e-05	0.000116	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.15e-05	0.000115	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTP1—malignant glioma	4.09e-05	0.000114	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FGF2—malignant glioma	4.09e-05	0.000114	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	4.09e-05	0.000114	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CASP3—malignant glioma	4.05e-05	0.000112	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—malignant glioma	4.04e-05	0.000112	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAT—malignant glioma	3.98e-05	0.000111	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTEN—malignant glioma	3.93e-05	0.000109	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—malignant glioma	3.92e-05	0.000109	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—malignant glioma	3.88e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.84e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—malignant glioma	3.83e-05	0.000106	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MDM2—malignant glioma	3.82e-05	0.000106	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RAF1—malignant glioma	3.81e-05	0.000106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTEN—malignant glioma	3.8e-05	0.000106	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.78e-05	0.000105	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ERBB2—malignant glioma	3.77e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTP1—malignant glioma	3.76e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NCOR1—malignant glioma	3.76e-05	0.000104	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTP1—malignant glioma	3.73e-05	0.000104	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	3.72e-05	0.000103	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AKT1—malignant glioma	3.71e-05	0.000103	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAT—malignant glioma	3.66e-05	0.000102	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAT—malignant glioma	3.63e-05	0.000101	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MYC—malignant glioma	3.6e-05	0.0001	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL8—malignant glioma	3.57e-05	9.93e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGFR—malignant glioma	3.53e-05	9.8e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NCOR1—malignant glioma	3.46e-05	9.6e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	3.45e-05	9.6e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—malignant glioma	3.43e-05	9.55e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NCOR1—malignant glioma	3.43e-05	9.52e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CASP3—malignant glioma	3.42e-05	9.51e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—malignant glioma	3.42e-05	9.49e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CA—malignant glioma	3.41e-05	9.48e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—malignant glioma	3.4e-05	9.45e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—KRAS—malignant glioma	3.33e-05	9.25e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—malignant glioma	3.23e-05	8.98e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTEN—malignant glioma	3.21e-05	8.93e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MYC—malignant glioma	3.16e-05	8.78e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT1—malignant glioma	3.14e-05	8.71e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGFR—malignant glioma	3.09e-05	8.59e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAV1—malignant glioma	3.06e-05	8.51e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	3.06e-05	8.5e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—malignant glioma	2.96e-05	8.23e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.93e-05	8.13e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KRAS—malignant glioma	2.92e-05	8.12e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—malignant glioma	2.9e-05	8.07e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—malignant glioma	2.87e-05	7.99e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAV1—malignant glioma	2.82e-05	7.83e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAV1—malignant glioma	2.79e-05	7.76e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.79e-05	7.75e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKT1—malignant glioma	2.79e-05	7.75e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CA—malignant glioma	2.77e-05	7.71e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—malignant glioma	2.69e-05	7.48e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	2.68e-05	7.46e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MYC—malignant glioma	2.67e-05	7.42e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.67e-05	7.42e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGFR—malignant glioma	2.61e-05	7.26e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—malignant glioma	2.6e-05	7.21e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.57e-05	7.13e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.54e-05	7.07e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT1—malignant glioma	2.5e-05	6.95e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—malignant glioma	2.48e-05	6.88e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KRAS—malignant glioma	2.47e-05	6.86e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—malignant glioma	2.46e-05	6.82e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.45e-05	6.82e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	2.27e-05	6.3e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKT1—malignant glioma	2.27e-05	6.3e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.26e-05	6.27e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.24e-05	6.22e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—malignant glioma	2.19e-05	6.1e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT1—malignant glioma	2.19e-05	6.09e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.14e-05	5.94e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—malignant glioma	2.12e-05	5.89e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.97e-05	5.46e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.95e-05	5.42e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—malignant glioma	1.95e-05	5.41e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—malignant glioma	1.93e-05	5.37e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT1—malignant glioma	1.85e-05	5.15e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTEN—malignant glioma	1.85e-05	5.13e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTEN—malignant glioma	1.7e-05	4.72e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTEN—malignant glioma	1.68e-05	4.68e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.3e-05	3.62e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.2e-05	3.33e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.19e-05	3.3e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKT1—malignant glioma	1.06e-05	2.96e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKT1—malignant glioma	9.79e-06	2.72e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKT1—malignant glioma	9.71e-06	2.7e-05	CbGpPWpGaD
